Neurology

Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.

Patients with MS have a high incidence of calcium phosphate stones and struvite stones, study finds.

Genetic variants influences the risk of MS and other autoimmune disorders.

Variants of the IL7R and DDX39B genes may lead to increased risk of multiple sclerosis.

Identification of genetic variants may improve diagnosis of MS.

Top five most popular articles this week on Specialty Pharmacy Times.

Current treatment options for MS help limit relapses, but are unable to reverse the damage the disease has already caused.

The multiple sclerosis (MS) community eagerly awaited the March 28 FDA approval of ocrelizumab (Ocrevus) for treating relapsing and primary progressive forms of MS. -

Ocrelizumab (Ocrevus) granted FDA approval to treat 2 forms of MS.

Novel test demonstrates the benefits of exercise in individuals with neurological injuries and illnesses.

Neurologist Michael Racke, MD, discusses the new FDA approval of ocrelizumab and how it will impact the future treatment of MS.

Findings open the door for new therapeutic options for myelin regeneration in multiple sclerosis.

Equine-assisted therapy improved motor function in cerebral palsy and multiple sclerosis.

Genentech’s $100,000 grant will fund a home-based telemedicine program.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

A recent study has suggested that starting patients on multiple sclerosis medication soon after they show initial signs of the disease could prolong the time before the condition becomes fully diagnosable.

Multiple sclerosis is an incurable immune-mediated inflammatory disease that produces symptomatic episodes months or years apart in different anatomic locations.

Test delivers the results of a multiple sclerosis diagnosis in as few as 7 days.

New MS diagnoses are steadily on the rise.

New Alexa skill helps spread MS education and awareness.

Fatigue and limitations in leg function may increase progress from relapsing-remitting MS to secondary progressive MS in older adults.

Individuals with MS are 3 to 6 times more likely to develop seizures.

The challenges of living a normal, active life while managing multiple sclerosis.

Genetics that determine physical traits may play a large role in prevalence of conditions such as multiple sclerosis, autism, and diabetes.